Literature DB >> 18203778

PEComa: another member of the MiT tumor family?

Alberto Righi1, Kypros Dimosthenous, Juan Rosai.   

Abstract

We report 2 cases of PEComa, one occurring in the colon of an 11-year-old boy and the other in the bone (fibula) of a 92-year-old woman. Both tumors consisted of nests of large epithelioid cells surrounded by a fibrovascular stroma. The nuclei were large and vesicular, with prominent centrally located nucleoli. The cytoplasm was eosinophilic, with a fine to coarse granularity. Mitoses and individual cell necrosis were infrequent. Immunohistochemically, both tumors showed strong cytoplasmic expression of HMB-45 and intense nuclear positivity for TFE3. To our knowledge, nuclear positivity for TFE3 has been previously reported in only 5 cases of PEComa. Reactivity to this marker suggests that PEComa should be added to the growing list of human tumors of the so-called MiT family gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203778     DOI: 10.1177/1066896907309733

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  16 in total

1.  Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.

Authors:  Qin Shen; Qiu Rao; Qiu-Yuan Xia; Bo Yu; Qun-Li Shi; Ru-Song Zhang; Xiao-Jun Zhou
Journal:  Virchows Arch       Date:  2014-09-20       Impact factor: 4.064

Review 2.  Primary perivascular epithelioid cell neoplasm (PEComa) of bone: report of two cases and review of the literature.

Authors:  Nicholas M Desy; Mitchell Bernstein; Ayoub Nahal; Mohamed Aziz; Samuel Kenan; Robert E Turcotte; Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2012-07-03       Impact factor: 2.199

3.  A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.

Authors:  Chisato Ohe; Naoto Kuroda; Ondrej Hes; Michal Michal; Tomas Vanecek; Petr Grossmann; Yukichi Tanaka; Mio Tanaka; Hidekazu Inui; Yoshihiro Komai; Tadashi Matsuda; Yoshiko Uemura
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

Review 4.  Perivascular epithelioid cell tumor in the duodenum: challenge in differential diagnosis.

Authors:  Zehong Chen; Huijuan Shi; Jianjun Peng; Yujie Yuan; Jianhui Chen; Wu Song
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.

Authors:  Martin D Hyrcza; Daniel A Winer; Mary Shago; Karolyn Au; Gelareh Zadeh; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

6.  Cathepsin K in the immunohistochemical diagnosis of melanocytic lesions.

Authors:  Qiu Rao; Yan Wang; Qiu-Yuan Xia; Shan-Shan Shi; Qin Shen; Pin Tu; Qun-Li Shi; Xiao-Jun Zhou; Bo Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

7.  Perivascular epithelioid cell tumor (PEComa) of the ascending colon: the implication of IFN-α2b treatment.

Authors:  Sun Ju Park; Dong Kyun Han; Hee Jo Baek; Sang Young Chung; Jong Hee Nam; Hoon Kook; Tai Ju Hwang
Journal:  Korean J Pediatr       Date:  2010-11-30

Review 8.  Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review.

Authors:  I Weng Lao; Lin Yu; Jian Wang
Journal:  Diagn Pathol       Date:  2015-05-29       Impact factor: 2.644

Review 9.  Perivascular epithelioid cell tumor of the rectum: report of a case and review of the literature.

Authors:  Amane Kanazawa; Shoichi Fujii; Ten-i Godai; Atsushi Ishibe; Takashi Oshima; Tadao Fukushima; Mitsuyoshi Ota; Norio Yukawa; Yasushi Rino; Toshio Imada; Junko Ito; Akinori Nozawa; Munetaka Masuda; Chikara Kunisaki
Journal:  World J Surg Oncol       Date:  2014-01-13       Impact factor: 2.754

Review 10.  PEComa of the uterus with coexistence of situs inversus totalis, a case report and literature review.

Authors:  Yang Han; Ting-ting Liu; Xue-shan Qiu; Qing-chang Li; Yi Zhao; Xiao-Yan Pang; En-hua Wang
Journal:  Diagn Pathol       Date:  2015-08-14       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.